June 17, 2008 - Pharmalot -- So many obstacles that one wag speculates the road to biosimilars - or follow-on biologics or biogenerics - may not be paved until 2010, or even 2012. What’s standing in the way? All sorts of things, writes Ramsey Baghdadi in The RPM Report.
